Standard BioTools EBITDA 2010-2025 | LAB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Standard BioTools ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Standard BioTools ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.6B
Tempus AI (TEM)	$12.1B
Doximity (DOCS)	$12B
Hims & Hers Health (HIMS)	$10.8B
IRhythm Technologies (IRTC)	$5.4B
Hinge Health (HNGE)	$4.5B
Inspire Medical Systems (INSP)	$2.6B
Privia Health (PRVA)	$2.6B
Phreesia (PHR)	$1.7B
Enovis (ENOV)	$1.7B
10x Genomics (TXG)	$1.7B
Azenta (AZTA)	$1.5B
Schrodinger (SDGR)	$1.5B
Omnicell (OMCL)	$1.4B
Clover Health Investments (CLOV)	$1.3B
Claritev (CTEV)	$1.2B
Evolent Health (EVH)	$1.1B
Fulgent Genetics (FLGT)	$666M
Veradigm (MDRX)	$509M
Zepp Health (ZEPP)	$504M
Talkspace (TALK)	$432M
Carlsmed (CARL)	$365M
Butterfly Network (BFLY)	$357M
TruBridge (TBRG)	$300M
Outset Medical (OM)	$235M
Health Catalyst (HCAT)	$227M
Nyxoah SA (NYXH)	$215M
SOPHiA GENETICS SA (SOPH)	$210M
KORU Medical Systems (KRMD)	$199M
CapsoVision (CV)	$189M